Welcome to DZIF
It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.
DZIF at the ICAAC 2015
The DZIF will be present at the ICAAC: The premier conference on antimicrobial agents and infectious diseases showcases the latest-breaking science and lectures from top researchers from around the world. Booth No. 618
MERS-Coronavirus: Clinical tests of a vaccine are in preparation
DZIF scientists from the LMU München have successfully tested a candidate vaccine in animal models and are now preparing a clinical trial in humans.
In the DZIF, scientists prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus.
Fighting HIV with Antibodies
An international team of scientists, in collaboration with the DZIF, has now tested a new generation of antibodies in humans for the first time. They have demonstrated that these broadly neutralising antibodies significantly reduce the number of human immunodeficiency viruses (HIV) in infected patients’ blood.
20 July 2015 - PRESS RELEASE
The DZIF Academy is pleased to open the call for application for the second DZIF Prize for Translational Infection Research. DZIF will award a prize of 5.000 Euro for exceptional translational infection research. Candidates who significantly contributed to infection research in Germany can either be nominated by their mentors or apply directly to the DZIF Academy. [ more ]
24 June 2015 - PRESS RELEASE
09 June 2015 - PRESS RELEASE